ArticleCell cycle (Georgetown, Tex.)2012

Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: insights from zebrafish genetics.

Yonghe Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.